688131 皓元醫藥
按盤價 
33.530 +5.590 (+20.007%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.745 | 5.278 | 9.350 | 16.253 | 27.693 |
| 總資產報酬率 ROA (%) | 1.644 | 3.272 | 6.474 | 11.784 | 18.356 |
| 投入資產回報率 ROIC (%) | 1.864 | 3.785 | 7.555 | 13.863 | 22.771 | 邊際利潤分析 |
| 銷售毛利率 (%) | 45.375 | 45.168 | 51.444 | 54.118 | 56.674 |
| 營業利潤率 (%) | 7.435 | 6.826 | 14.474 | 21.641 | 23.412 |
| 息稅前利潤/營業總收入 (%) | 8.736 | 8.513 | 14.577 | 22.261 | 24.787 |
| 淨利潤/營業總收入 (%) | 6.529 | 6.718 | 14.105 | 19.662 | 20.223 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 173.176 | 161.741 | 107.449 | 109.025 | 113.942 |
| 價值變動淨收益/利潤總額(%) | -6.670 | -3.723 | 8.085 | -0.057 | 0.978 |
| 營業外收支淨額/利潤總額(%) | 0.209 | -0.106 | 0.995 | -0.111 | -0.051 | 償債能力分析 |
| 流動比率 (X) | 1.960 | 1.880 | 2.217 | 4.944 | 2.160 |
| 速動比率 (X) | 0.991 | 0.896 | 1.109 | 3.849 | 1.384 |
| 資產負債率 (%) | 39.558 | 39.739 | 35.183 | 22.986 | 38.401 |
| 帶息債務/全部投入資本 (%) | 24.643 | 24.232 | 15.367 | 0.695 | 18.809 |
| 股東權益/帶息債務 (%) | 273.965 | 282.011 | 492.789 | 12,717.344 | 405.343 |
| 股東權益/負債合計 (%) | 151.538 | 150.611 | 183.280 | 332.471 | 160.412 |
| 利息保障倍數 (X) | 6.793 | 5.025 | -342.766 | 34.569 | 17.871 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 85.890 | 75.320 | 63.743 | 41.668 | 37.542 |
| 存貨周轉天數 (天) | 350.758 | 359.057 | 344.748 | 235.069 | 247.717 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
